Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Payables (2016 - 2025)

SRx Health Solutions' Payables history spans 15 years, with the latest figure at $2.1 million for Q3 2025.

  • For Q3 2025, Payables fell 95.07% year-over-year to $2.1 million; the TTM value through Sep 2025 reached $2.1 million, down 95.07%, while the annual FY2025 figure was $2.1 million, N/A changed from the prior year.
  • Payables reached $2.1 million in Q3 2025 per SRXH's latest filing, down from $42.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $43.6 million in Q3 2024 to a low of $100000.0 in Q3 2023.
  • Average Payables over 5 years is $8.1 million, with a median of $4.4 million recorded in 2025.
  • Peak YoY movement for Payables: tumbled 97.4% in 2023, then skyrocketed 43457.0% in 2024.
  • A 5-year view of Payables shows it stood at $4.6 million in 2021, then crashed by 35.6% to $2.9 million in 2022, then skyrocketed by 141.81% to $7.1 million in 2023, then tumbled by 55.75% to $3.1 million in 2024, then tumbled by 31.56% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Payables are $2.1 million (Q3 2025), $42.1 million (Q2 2025), and $4.4 million (Q1 2025).